Intelligensys Ltd, Springboard Business Centre, Stokesley Business Park, Stokesley, North Yorkshire TS95JZ, UK.
Future Med Chem. 2009 Jul;1(4):713-26. doi: 10.4155/fmc.09.57.
The development of commercial pharmaceutical formulations can involve extensive experimentation that generates a large amount of data. Understanding such data and discovering the key relationships within them can be a complex process, adding considerably to the time and expense taken to get a product to market. However, new computational techniques such as neural and evolutionary computing have the potential to accelerate the mining and modeling of data, and these methodologies are now being packaged in a way that makes them readily accessible to the product formulator. This article outlines the basis of these technologies and reviews their use in pharmaceutical formulation, showing that they have gained acceptance as practical research tools, especially when integrated with complementary optimization and visualization tools. Neural and evolutionary computing are gaining widespread acceptance in the field of pharmaceutical formulation, with results being comparable with, or better than, those from traditional statistical methods.
商业制药制剂的开发可能涉及广泛的实验,产生大量的数据。理解这些数据并发现其中的关键关系可能是一个复杂的过程,这会大大增加将产品推向市场所需的时间和费用。然而,神经计算和进化计算等新的计算技术有可能加速数据的挖掘和建模,现在这些方法被打包成一种产品配方师易于使用的形式。本文概述了这些技术的基础,并回顾了它们在药物制剂中的应用,表明它们已经作为实用的研究工具被接受,尤其是与互补的优化和可视化工具集成使用时。神经计算和进化计算在药物制剂领域得到了广泛的认可,其结果可与传统统计方法相媲美,甚至更好。